Mandate

Acquisition of Lideta Hälsovård

November 10, 2017 M&A

Vinge is advising Nordstjernan in conjunction with the acquisition of a majority of the shares in Lideta Hälsovård.

Lideta conducts primary care via 15 centres in Stockholm and in southern Sweden. The company has grown quickly since it was founded in 2001 by doctor Simon Larsson and currently has 93 000 listed patients, 350 employees and a turnover of approximately MSEK 500.

The transaction is conditional upon approval by the relevant competition authorities, which is expected during the fourth quarter of 2017.

Vinge’s team consisted of partners Johan Winnerblad and Kristina Ekberg, associates Samra Baytar, Johanna Wiberg and Marion Kronberg. Grant McKelvey and Xandra Ståhlberg provided competition law advice.

Related

Vinge has advised Investor in connection with acquisition of shares in EQT

Vinge has advised Investor in connection with an acquisition of 12,500,000 shares in EQT AB from Wallenberg Investments for a total consideration of approximately SEK 3.5 billion.
October 19, 2026

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026